FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087762014> ?p ?o ?g. }

• W2087762014 endingPage "F248" @default.
• W2087762014 startingPage "F247" @default.
• W2087762014 abstract "EDITORIAL FOCUSPhospho-specific antibodies: more valuable than originally thoughtR. Tyler MillerR. Tyler MillerPublished Online:01 Aug 2005https://doi.org/10.1152/ajprenal.00077.2005MoreSectionsPDF (39 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat the kidney succeeds in determining body composition not only because of the complex arrangement of transporters along the nephron but also because these transporters are regulated by extracellular signals so that the kidney can respond appropriately to a range of physiological conditions. Protein phosphorylation is one of the principal regulatory mechanisms that control the activities and behavior of kinases, channels, enzymes, and structural proteins, so determining their phosphorylation state is an essential part of understanding their regulation. Over the last 20 years, phospho-specific antibodies have been enormously useful in defining regulatory mechanisms that control cell functions. In many laboratories, these reagents are used as definitive assays for the phosphorylation state of proteins, and we forget how difficult life was before their advent. Consequently, the creation of phospho-specific antibodies that recognize two sites in the type 3 Na/H exchanger (NHE3) by Kocinski et al. (4) may not seem like a major achievement. However, these reagents make practical studies that address the fundamental physiological role of NHE3 that would be impossible or extremely cumbersome otherwise.Studies with the first phospho-specific antibody, an anti-phosphotyrosine antibody, were published in 1984, and demonstrated phosphorylation of the PDGF receptor in response to binding its ligand, PDGF, in intact cells (1). At that time, antibodies that could immunoprecipitate the PDGF receptor did not exist, and although phosphorylation of the receptor had been demonstrated using purified proteins and standard biochemical techniques, whether this receptor was truly phosphorylated in response to PDGF in vivo could not be determined. The anti-phosphotyrosine antibody was used to immunoprecipitate the PDGF receptor following treatment of the cells with PDGF and 32P. This antibody allowed partial purification of the receptor to the point that its phosphorylation could be recognized with autoradiography, so that specific phosphorylation of it on tyrosine residues could be demonstrated. This and subsequent anti-phosphotyrosine antibodies led to the specific identification of other proteins containing phosphotyrosines and additional proteins that interact with these proteins. In many cases, these antibodies recognized their targets in cells and tissues, so that the precise location of phosphoproteins in the cell could be determined, analyses that cannot be performed using standard biochemical techniques.Kocinski et al. (4) describe the creation of monoclonal and polyclonal antibodies that recognize two sites on NHE3 that are phosphorylated by PKA, serine 552 and serine 605. NHE3 is one of the principal transporters responsible for Na and HCO3 reabsorption in the kidney and intestine, and consequently, its regulation is essential to allow adaptation to a range of physiological states (7). As would be expected, the activity of this transporter is regulated by multiple mechanisms involving processes that include phosphorylation, dephosphorylation, trafficking, and association with a variety of proteins in response to hormones, changes in osmolarity, blood pressure, and pH (7).Under most experimental conditions, NHE3 is active in its basal state and subject to inhibition by factors that stimulate cAMP and PKA. In response to parathyroid hormone (PTH) and dopamine, NHE3 is phosphorylated on its COOH terminus by PKA at serine 552 and serine 605, its transport activity is decreased, and this decrease in activity is associated with reduced levels of membrane-associated transporters (5, 10). NHE3 interacts with two scaffolding proteins, NHERF and PDZK1. NHERF also binds ezrin, a protein that functions as a PKA-binding protein. PDZK1, a multivalent PDZ domain-containing protein, also binds D-AKAP-2, another PKA binding protein (2, 3, 6, 8). These scaffolding proteins may enhance the effect of cAMP by localizing the transporter near the kinase and ensuring efficient phosphorylation. Phosphorylation of NHE3 then leads to internalization and reduced activity (9).For practical reasons, these studies of NHE3 regulation have been carried out primarily in cell culture and with expressed proteins. Although the mechanisms identified are almost certainly correct, studies that address the phosphorylation state of NHE3, its interaction with scaffolding proteins, colocalization of kinases, and the way in which these factors determine localization of the transporter in intact tissues and cells have not been performed because current cell biological and biochemical approaches do not permit preservation of tissue and cell structure with simultaneous analysis of the phosphorylation state of NHE3.The paper by Kocinsky et al. (4) in this issue of American Journal of Physiology-Renal Physiology not only describes the production of anti-phosphoserine antibodies that can determine the phosphorylation state of NHE3 at two sites known to be PKA substrates but also demonstrates that under basal conditions, serine 552 is phosphorylated to a greater degree than serine 605 and that the NHE3 that is phosphorylated on serine 552 is preferentially localized to the coated-pit region of the brush border, where it is inactive. These results suggest that the phosphorylation state of NHE3 is an important factor in determining its subcellular localization, and by implication, its pattern of interaction with other proteins. NHE3 may associate with distinct sets of proteins in different cell compartments. The conditions and location within the cell where NHE3 associates with its scaffolding proteins are not fully defined. Although serine 552 and serine 605 are phosphorylated by PKA, they may also be phosphorylated by other kinases, or PKA may be activated under conditions that are independent of classical ligands for receptors that couple to Gαs and adenylyl cyclase. Segregation of NHE3 in the cell without changes in the phosphorylation state of serine 552 or serine 605 will provide compelling evidence for additional regulatory pathways to be explored. These issues as well as others are now accessible for study in intact tissue or may be studied more efficiently in model systems with these new reagents. Although the concept of phospho-specific antibodies is not as novel as it was 20 years ago, the utility of the reagents and their ability to advance biology in physiologically relevant experimental systems remain.REFERENCES1 Frackelton AR, Tremble PM, and Williams LT. Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo. J Biol Chem 259: 7909–7915, 1984.Crossref | PubMed | ISI | Google Scholar2 Gisler SM, Madjdpour C, Bacic D, Pribanec S, Taylor S, Biber J, and Murer H. PDZK1. II. An anchoring site for the PKA binding protein D-AKAP-2 in renal proximal tubular cells. Kidney Int 64: 1746–1754, 2003.Crossref | PubMed | ISI | Google Scholar3 Gisler SM, Pribanic S, Bacic D, Forrer P, Gantenbein A, Sabourin LA, Tsuji A, Zhao ZS, Manser E, Biber J, and Murer H. PDZK1. I. A major scaffolder in brush border proximal tubular cells. Kidney Int 64: 1733–1745, 2003.Crossref | PubMed | ISI | Google Scholar4 Kocinsky HS, Girardi ACC, Biemsderfer D, Nguyen T, Mentone SA, Orlowski J, and Aronson PS. Use of phosphospecific antibodies to determine the phosphorylation of endogenous Na/H exchanger NHE3 at PKA consensus sites. Am J Physiol Renal Physiol 289: F249–F258, 2005.Link | ISI | Google Scholar5 Kurashima K, Yu FH, Cabado AG, Szabo EZ, Grinstein S, and Orlowski J. Identification of sites required for downregulation of Na/H exchanger NHE3 activity by cAMP-dependent protein kinase. J Biol Chem 272: 28672–28679, 1997.Crossref | PubMed | ISI | Google Scholar6 Moe OW. Scaffolds: orchestrating proteins to achieve concerted functions. Kidney Int 64: 1916–1917, 2003.Crossref | PubMed | ISI | Google Scholar7 Orlowski J and Grinstein S. Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflügers Arch 47: 549–565, 2004.Google Scholar8 Weinman EJ, Wang Y, Wang F, Greer C, Steplock D, and Shenolikar S. A C-terminal PDZ motif in NHE3 binds NHERF-1 and enhances cAMP inhibition of sodium-hydrogen exchange. Biochemistry 42: 12662–12668, 2003.Crossref | PubMed | ISI | Google Scholar9 Yang LE, Maunsbach AB, Leong PK, and McDonough AA. Differential traffic of proximal tubule Na transporters during hypertension or PTH: NHE3 to base of microvilli vs. NaPi2 to endosomes. Am J Physiol Renal Physiol 287: F896–F906, 2004.Link | ISI | Google Scholar10 Zhao H, Weiderkher MR, Fan L, Collazo RL, Crowder LA, and Moe OW. Acute inhibition of Na/H exchanger NHE3 by cAMP: role for protein kinase A and NHE-3 phosphoserines 552 and 605 (Abstract). J Biol Chem 274: 3987, 1999.Google ScholarAUTHOR NOTESAddress for reprint requests and other correspondence: R. T. Miller, Dept. of Medicine, Case Western Reserve Univ., Div. of Nephrology, Louis Stokes Veterans Affairs Medical Ctr., 10701 East Blvd., Cleveland, OH 44106 (e-mail: [email protected]) Download PDF Previous Back to Top Next FiguresReferencesRelatedInformation Cited ByImmunolocalization of Phospho-Arg-Directed Protein Kinase-Substrate in Hypoxic KidneysMonolignol Pathway 4-Coumaric Acid:Coenzyme A Ligases in Populus. trichocarpa : Novel Specificity, Metabolic Regulation, and Simulation of Coenzyme A Ligation Fluxes 23 January 2013 | Plant Physiology, Vol. 161, No. 3Cyclic AMP-mediated endocytosis of intestinal epithelial NHE3 requires binding to synaptotagmin 1Mark W. Musch, Donna L. Arvans, Yunwei Wang, Yasushi Nakagawa, Elena Solomaha, and Eugene B. Chang1 February 2010 | American Journal of Physiology-Gastrointestinal and Liver Physiology, Vol. 298, No. 2Renal NHE3 and NaPi2 partition into distinct membrane domainsAnne D. M. Riquier, Donna H. Lee, and Alicia A. McDonough1 April 2009 | American Journal of Physiology-Cell Physiology, Vol. 296, No. 4Immunolocalization of phospho-Arg-directed protein kinase-substrate in hypoxic kidneys using in vivo cryotechnique18 March 2009 | Medical Molecular Morphology, Vol. 42, No. 1 More from this issue > Volume 289Issue 2August 2005Pages F247-F248 Copyright & PermissionsCopyright © 2005 the American Physiological Societyhttps://doi.org/10.1152/ajprenal.00077.2005PubMed16006590History Published online 1 August 2005 Published in print 1 August 2005 Metrics" @default.
• W2087762014 created "2016-06-24" @default.
• W2087762014 creator A5033861833 @default.
• W2087762014 date "2005-08-01" @default.
• W2087762014 modified "2023-09-27" @default.
• W2087762014 title "Phospho-specific antibodies: more valuable than originally thought" @default.
• W2087762014 cites W1570617743 @default.
• W2087762014 cites W1968660853 @default.
• W2087762014 cites W1986656184 @default.
• W2087762014 cites W1995975621 @default.
• W2087762014 cites W2014734668 @default.
• W2087762014 cites W2029702664 @default.
• W2087762014 cites W2057734442 @default.
• W2087762014 cites W2059251307 @default.
• W2087762014 cites W2073411380 @default.
• W2087762014 doi "https://doi.org/10.1152/ajprenal.00077.2005" @default.
• W2087762014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16006590" @default.
• W2087762014 hasPublicationYear "2005" @default.
• W2087762014 type Work @default.
• W2087762014 sameAs 2087762014 @default.
• W2087762014 citedByCount "6" @default.
• W2087762014 countsByYear W20877620142013 @default.
• W2087762014 countsByYear W20877620142016 @default.
• W2087762014 crossrefType "journal-article" @default.
• W2087762014 hasAuthorship W2087762014A5033861833 @default.
• W2087762014 hasConcept C15744967 @default.
• W2087762014 hasConcept C159654299 @default.
• W2087762014 hasConcept C203014093 @default.
• W2087762014 hasConcept C86803240 @default.
• W2087762014 hasConceptScore W2087762014C15744967 @default.
• W2087762014 hasConceptScore W2087762014C159654299 @default.
• W2087762014 hasConceptScore W2087762014C203014093 @default.
• W2087762014 hasConceptScore W2087762014C86803240 @default.
• W2087762014 hasIssue "2" @default.
• W2087762014 hasLocation W20877620141 @default.
• W2087762014 hasLocation W20877620142 @default.
• W2087762014 hasOpenAccess W2087762014 @default.
• W2087762014 hasPrimaryLocation W20877620141 @default.
• W2087762014 hasRelatedWork W1710126152 @default.
• W2087762014 hasRelatedWork W2053487507 @default.
• W2087762014 hasRelatedWork W2077865380 @default.
• W2087762014 hasRelatedWork W2134894512 @default.
• W2087762014 hasRelatedWork W2748952813 @default.
• W2087762014 hasRelatedWork W2765597752 @default.
• W2087762014 hasRelatedWork W2789488587 @default.
• W2087762014 hasRelatedWork W2899084033 @default.
• W2087762014 hasRelatedWork W2931662336 @default.
• W2087762014 hasRelatedWork W2958642381 @default.
• W2087762014 hasVolume "289" @default.
• W2087762014 isParatext "false" @default.
• W2087762014 isRetracted "false" @default.
• W2087762014 magId "2087762014" @default.
• W2087762014 workType "article" @default.